Natural killer (NK) cell activity of peripheral blood lymphocytes from patients with Bechterew's syndrome (ankylosing spondylitis). 1984

O Vinje, and O Førre, and M Degre, and P Møller

Sixteen patients with Bechterew's syndrome (ankylosing spondylitis, AS) were investigated. All except one of the patients were HLA B27-positive. Peripheral blood lymphocytes from the patients were examined for spontaneous cytotoxicity against 51Cr-labelled K562 target cells. The cytotoxicity index of the non-T lymphocytes was negatively correlated with the serum CRP concentration (Pearson's r = 0.613, p less than 0.02). This finding seems to be caused by an alteration of the natural killer (NK) cell activity of the non-T lymphocytes during the active phase of the disease and not due to serum factors. The activity of the non-T cell fraction was slightly but not significantly reduced in patients with high disease activity (CRP greater than 0.01 g/l) compared with normal controls, (14.6 +/- 2.8 g/l versus 20.4 +/- 2.4 g/l mean +/- SE; p less than 0.10) Serum IgG and IgA concentrations were increased (p less than 0.001 and p less than 0.05 respectively) Interferon caused normal augmentation in the NK cell activity in AS patients, and no correlation was found between serum gamma interferon titres and the NK cell activity.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

O Vinje, and O Førre, and M Degre, and P Møller
June 1989, Zhonghua wai ke za zhi [Chinese journal of surgery],
O Vinje, and O Førre, and M Degre, and P Møller
October 1982, British journal of cancer,
O Vinje, and O Førre, and M Degre, and P Møller
September 1986, Nihon Kyobu Shikkan Gakkai zasshi,
O Vinje, and O Førre, and M Degre, and P Møller
June 1981, Hiroshima journal of medical sciences,
O Vinje, and O Førre, and M Degre, and P Møller
June 1981, Casopis lekaru ceskych,
O Vinje, and O Førre, and M Degre, and P Møller
January 1985, Scandinavian journal of rheumatology,
O Vinje, and O Førre, and M Degre, and P Møller
September 1988, Annals of the rheumatic diseases,
O Vinje, and O Førre, and M Degre, and P Møller
December 1982, No shinkei geka. Neurological surgery,
O Vinje, and O Førre, and M Degre, and P Møller
April 1999, European journal of endocrinology,
Copied contents to your clipboard!